Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Link opens in a new tab
Search content at Illinois Experts
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Epigenetic targeting of platinum resistant testicular cancer
Daniel Sonnenburg
,
Michael J. Spinella
, Costantine Albany
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Epigenetic targeting of platinum resistant testicular cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Testicular Cancer
100%
Epigenetic Targeting
100%
Platinum Resistance
100%
Tumor
40%
Epigenetic Aberrations
40%
Highly Sensitive
20%
Cancer Cells
20%
Testicle
20%
Germ Cells
20%
Mini
20%
Clinical Setting
20%
DNA Methylation (DNAm)
20%
Cell-derived
20%
Epigenetic Modification
20%
DNA Hypomethylation
20%
Chemotherapy Resistance
20%
Refractory Cancer
20%
Poor Clinical Outcomes
20%
Clinical Specimens
20%
Demethylating Agents
20%
DNA Methyltransferase Inhibitor
20%
Epigenetic Profile
20%
Testicular Germ Cell Tumor
20%
Acquired Drug Resistance
20%
DNA Hypermethylation
20%
Epigenetic Drugs
20%
Refractory Germ Cell Tumor
20%
Platinum-refractory
20%
Medicine and Dentistry
Testis Cancer
100%
DNA Methylation
80%
Neoplasm
40%
Germinoma
40%
Malignant Neoplasm
20%
Cancer Cell
20%
Somatics
20%
Low Drug Dose
20%
Testes
20%
Drug Resistance
20%
Germ Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Testis Cancer
100%
Neoplasm
40%
Germ Cell Tumor
40%
Malignant Neoplasm
20%
Preclinical Study
20%
Chemotherapy
20%
Drug Resistance
20%